Antiphospholipid Syndrome
📧 Sign up to get email alerts when something new happens for Antiphospholipid Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome [Phase 2]
Phase 2 clinical trial evaluating hydroxychloroquine for endothelial dysfunction in antiphospholipid syndrome has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Medium-term Follow-up of Patients With Obstetric Antiphospholipid Syndrome: MRI Study of White Matter [NA]
This clinical trial update reports medium-term follow-up findings from patients with obstetric antiphospholipid syndrome. The study uses MRI…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Effect of Telitacicept on Antibody Titers in Primary APS Patients [Phase 2]
A Phase 2 trial evaluating the effect of Telitacicept on antibody titers in patients with primary antiphospholipid syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Obstetric Antiphospholipid Antibody Syndrome : Contribution of the Evaluation of ADAMTS13 Made at the Diagnosis of Pregnancy on Evaluation the Risk of Pre-eclampsia
A completed obstetric trial evaluating whether ADAMTS13 measurement at diagnosis of pregnancy in women with antiphospholipid antibody syndro…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Evaluation of the Incidence of Cancer in the Follow-up of Women With 3 Consecutive Embryonic Demises Before 10 Weeks or 1 Fetal Death, According to Their Thrombophilia Status, With a Special Focus on Women With an Obstetric Antiphospholipid Symdrome (oAPS)
A completed clinical study evaluating cancer incidence during follow-up of women with a history of three consecutive embryonic losses before…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Assessment of the Prevalence of Major Psychiatric Disorders in a Cohort of Women With Clinical Criteria Corresponding to Pure, Abortive-form, Obstetrical, Antiphospholipid Syndrome
The study evaluates the prevalence of major psychiatric disorders in women who meet clinical criteria for antiphospholipid syndrome and rela…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations
A completed clinical trial studied the prognostic value of PGF and sFlt1 biomarker variations induced by initial low-molecular-weight hepari…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Telitacicept in Primary APS Patients [Phase 2]
Phase 2 trial of telitacicept in primary antiphospholipid syndrome has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases [Phase 2]
Phase 2 clinical trial update on BCMA-CD19 CAR-T therapy for refractory autoimmune diseases, currently recruiting. The study targets several…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease [NA]
This clinical trial update reports a study of YTS109 cell injection for recurrent or refractory autoimmune diseases that is currently recrui…
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Effect of Injectable Anticoagulants on Research for a Circulating Lupus-type Anticoagulant [NA]
A completed clinical trial evaluated the impact of injectable anticoagulants on research involving a circulating lupus-type anticoagulant in…
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome [Phase 2]
Phase 2 clinical trial update for rivaroxaban in stroke patients with antiphospholipid syndrome and related autoimmune conditions.
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: Use of Warfarin After the First Trimester in Pregnant Women With APS [Phase 4]
Phase 4 trial updating use of warfarin after the first trimester in pregnant women with antiphospholipid syndrome and recurrent miscarriage.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome [Phase 4]
Phase 4 clinical trial update evaluating apixaban for secondary prevention of thromboembolism in patients with antiphospholipid syndrome has…
-
CLINICAL_TRIALS trial_result · 2023-01-13Clinical Trial Update: The BeLimumab Antiphospholipid Syndrome Trial (BLAST) [Phase 2, Phase 3]
Clinical trial update for the BeLimumab antiphospholipid syndrome study (BLAST) covering Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients [Phase 3]
A Phase 3 trial evaluating hydroxychloroquine for primary thrombosis prevention in antiphospholipid antibody–positive patients was terminate…
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome [Phase 4]
Phase 4 clinical trial investigating hydroxychloroquine sulfate for recurrent spontaneous abortion associated with antiphospholipid syndrome…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Rivaroxaban for Patients With Antiphospholipid Syndrome [Phase 3]
A Phase 3 clinical trial evaluating rivaroxaban for antiphospholipid syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients [Phase 2]
This update reports results from a Phase 2 clinical trial evaluating the effects of fluvastatin on proinflammatory and prothrombotic markers…
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Rivaroxaban in Thrombotic Antiphospholipid Syndrome [Phase 3]
Phase 3 trial update for rivaroxaban in antiphospholipid syndrome; study terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Timing of Initiation of LMWH Administration in Pregnant Women With APS [Phase 4]
Phase 4 trial update on the optimal timing to initiate low molecular weight heparin in pregnant women with antiphospholipid syndrome. The co…
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome [Phase 2]
A Phase 2 pilot trial evaluated Rituximab for anticoagulation-resistant manifestations of antiphospholipid syndrome; results from the comple…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome [Phase 2]
Phase IIa trial of ALXN1007 for non-criteria manifestations of antiphospholipid syndrome was terminated; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)
This completed trial assessed whether hydroxychloroquine affects AnxA5 resistance in antiphospholipid antibody–positive patients, with and w…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
This clinical trial update reports pharmacokinetic data for low molecular weight heparin and unfractionated heparin in pregnant participants…